human neuronal progenitor cells expressing IGF-1 fusion protein (GlaxoSmithKline)

N/A

Report date: 2025/03/20 14:54:21

Base Information

Drug Namehuman neuronal progenitor cells expressing IGF-1 fusion protein (GlaxoSmithKline)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionInsulin-like growth factor I receptor modulators
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeN/A
Related LinksN/A